Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV.
Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV.
Active, not recruiting · NCT06332339 · Registry updated 2024-11-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV. | HIV | Active, not recruiting | Phase 1 | 2024-11-05 | NCT06332339 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alabama CRS | Birmingham | United States | 2 |
| Brigham and Women's Hospital Vaccine CRS (BWH VCRS) | Boston | United States | 2 |
| Columbia P&S CRS | New York | United States | 4 |
| The Hope Clinic of the Emory Vaccine Center CRS Site# 31440 | Decatur | United States | 1 |
| University of Pennsylvania HIV Therapeutics and Prevention Clinical Trials Unit | Philadelphia | United States | 1 |
| University of Rochester HIV/AIDS CTU | Rochester | United States | 1 |